GCIInspiration Healthcare receives order from Sri Lankan Ministry of Health
The global medical technology company said its workstations are used for diagnosing Hypoxic-Ischaemic Encephalopathy, a brain injury induced by oxygen deprivation to the brain in the newborn.
The workstations comprise of Unique+ CFM, a cerebral function monitor for diagnosing brain injury, and, the Tecotherm Neo, used to cool and warm babies who have suffered from a lack of oxygen at the time of birth, the statement detailed.
Shares in Inspiration Healthcare were trading flat at 67p on Monday afternoon.
Neil Campbell, Inspiration Healthcare's Chief Executive said the order meant an “ever-growing presence” for the company across international markets.
“It also demonstrates clearly the quality of our products and our International distribution partners who are opening up these new opportunities,” he added.
The global market for foetal and neonatal medical equipment is estimated to reach a total $11.86 billion by 2022, the group highlighted within its 2019 annual report.
Follow News & Updates from Inspiration Healthcare here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.